Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

CAI Q3 2013 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M

Gross Profit

$37M67.7% margin

Operating Income

$25M46.8% margin

Net Income

$15M28.5% margin

EPS (Diluted)

$0.68

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

-$20M

Stock-Based Comp.

$433,000

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$1.2B

Stockholders' Equity

$398M

Cash & Equivalents

$36M

← FY 2013 All Quarters Q4 2013 →